<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To identify and assess mutations in the K-ras and BRAF genes in a cohort of Chinese patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) for their association with various clinicopathological parameters and prognosis </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Genomic DNA was isolated from frozen tissues </plain></SENT>
<SENT sid="2" pm="."><plain>Pyrosequencing analysis was conducted to detect mutations in the K-ras (codons 12, 13, and 61) and BRAF genes (codon 600) </plain></SENT>
<SENT sid="3" pm="."><plain>Statistical analysis was carried out using SPSS-15.0 software </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Among the 118 colorectal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients, we detected 41 (34.7%) mutations in the K-ras gene </plain></SENT>
<SENT sid="5" pm="."><plain>Mutation frequencies at codon 12 and codon 13 were 23.7% (28/118) and 10.2% (12/118), respectively </plain></SENT>
<SENT sid="6" pm="."><plain>Only one patient harbored a point mutation at codon 61 (0.8%, 1/118) </plain></SENT>
<SENT sid="7" pm="."><plain>Gender was the only factor that showed an obvious relationship with K-ras gene mutation (female 44.7% vs male 28.2%, P = 0.037) </plain></SENT>
<SENT sid="8" pm="."><plain>Other clinicopathological features, such as age, location of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> differentiation, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e>, Node and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">Metastases</z:e> classification, and the Union for International <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Control staging, showed no positive relationship with K-ras gene mutations </plain></SENT>
<SENT sid="9" pm="."><plain>No significant correlation was observed between the presence of K-ras mutations (codons 12, 13, and 61) and the survival of the patients </plain></SENT>
<SENT sid="10" pm="."><plain>BRAF mutations were rare, and only two patients (1.7%) harbored a detectable mutation at codon 600 </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: K-ras gene mutation is a common event in our 118 Chinese <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients, with an obvious relationship with gender </plain></SENT>
<SENT sid="12" pm="."><plain>However, it seems not to be an independent prognostic factor in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients </plain></SENT>
<SENT sid="13" pm="."><plain>The BRAF gene is rarely mutated in Chinese <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients </plain></SENT>
</text></document>